The global Dacryocystitis market is anticipated to grow at a CAGR during the forecast period. Dacryocystitis is an infection or inflammation of the nasolacrimal sac, usually escorted by obstruction of the nasolacrimal duct. Dacryocystitis can be acute or chronic and congenital or acquired. It is more common in females. It tends to occur either in infants (uncommon) or in adults (much more common) over the age of 40 years, peak age 60-70 years. The global Dacryocystitis market is driven by the rising prevalence of eye infections among the population globally. Due to this, the demand for effective treatment to cure Dacryocystitis is surging, thereby, leading to market growth. As per the National Institute of Health, in 2017, around 6-30% of the general population and up to 30% of the children across the globe were affected with conjunctivitis. Besides, 1 in 300 people suffer from an eye infection including Dacryocystitis each year. In addition, as per the CDC, every year, Americans make nearly a million doctor visits for eye infections, resulting in $175 million in direct health care costs. Owing to the high prevalence rate and healthcare expenditure, the market is showing impressive growth.
Moreover, rapid technological advancements in the field of ophthalmology and increasing surgical procedures associated with eye infections are the other factors that are further projected to accelerate the market growth. However, lack of awareness among patients about the infection may hamper the market growth, whereas new product launches by the key players operating in the market and emerging markets in major economies can bring lucrative growth opportunities in the Dacryocystitis market during the forecast period.
To Request a Sample of our Report on Dacryocystitis Market: https://www.omrglobal.com/request-sample/dacryocystitis-market-size
Dacryocystitis Market – Segmentation
By Indication
- Acute
- Chronic
- Others
A full Report of Dacryocystitis Market is Available @ https://www.omrglobal.com/industry-reports/dacryocystitis-market
Dacryocystitis Market – Segmentation by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Akorn, Inc.
- Alembic Pharmaceuticals Ltd.
- Aurobindo Pharma Ltd.
- Bess Medizintechnik GmbH
- Cigna
- Cipla Ltd.
- Eyevance Pharmaceuticals
- Gunther Weiss Scientific Glass Co. Inc.
- FCI Ophthalmics
- GlaxoSmithKline Plc
- Kaneka Corp.
- LABIANA GROUP
- Merck & Co. Inc.
- Mylan NV
- Nosch
- Novartis International AG
- Orex Pharma Pvt. Ltd.
- Perrigo Co.
- Pfizer Inc.
- PRODECO PHARMA Srl
- Rexall Pharmacy Group Ltd. (McKesson Corp.)
- Teligent, Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
